Fibroblast growth factor receptor 4 Gly388Arg polymorphism in Chinese gastric cancer patients. - Wikidata - wikimedia - TriplyDB

Fibroblast growth factor receptor 4 Gly388Arg polymorphism in Chinese gastric cancer patients.

Fibroblast growth factor receptor 4 Gly388Arg polymorphism in Chinese gastric cancer patients.

http://www.wikidata.org/entity/Q37050510

about

Second-line treatment of metastatic gastric cancer: Current options and future directions Functional FGFR4 Gly388Arg polymorphism contributes to cancer susceptibility: Evidence from meta-analysis.Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors.Fibroblast growth factor receptor 4 polymorphism is associated with liver cirrhosis in hepatocarcinoma Prognostic significance of fibroblast growth factor receptor 4 polymorphisms on biochemical recurrence after radical prostatectomy in a Chinese population.A novel gene expression-based prognostic scoring system to predict survival in gastric cancer.FGFR4 Arg388 Is Correlated with Poor Survival in Resected Colon Cancer Promoting Epithelial to Mesenchymal Transition.

P2860

Q26778027-8EBE8875-CB00-4152-BB00-F9F2847FC96C Q33648854-46D8B6EE-C2AD-4A50-A769-9F2C04807F09 Q34525925-27C2357C-1F0D-4EBC-9EEE-76B20C7E63E0 Q35364559-1A7FFED6-F92F-46C9-9962-9BA57082AEDB Q37264491-180D519C-26C2-4235-A43C-F7A784C00CD9 Q37688244-D11D5D0E-0BF9-463E-AD82-36F51CBC078B Q52960616-3A2EFC96-2E76-42FA-8BD9-83F6D0E248AD

P2860

Fibroblast growth factor receptor 4 Gly388Arg polymorphism in Chinese gastric cancer patients.

http://www.wikidata.org/entity/Q37050510

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Fibroblast growth factor recep ...... inese gastric cancer patients.

@en

Fibroblast growth factor recep ...... inese gastric cancer patients.

@nl

type

label

Fibroblast growth factor recep ...... inese gastric cancer patients.

@en

Fibroblast growth factor recep ...... inese gastric cancer patients.

@nl

prefLabel

Fibroblast growth factor recep ...... inese gastric cancer patients.

@en

Fibroblast growth factor recep ...... inese gastric cancer patients.

@nl

P1433

Q37050510-3CCF2ADB-FAE5-4FB6-859A-E62531CAD739

P1476

Q37050510-A1184A8F-D233-4BA2-AA69-C9E144183A29

P2093

Q37050510-034B65F5-73D6-4500-BF2B-A41D58E65E7B

Q37050510-2070EFCF-8EEB-420F-A277-1283E9C45B5E

Q37050510-349B6979-BBDC-4D24-8598-6713D50D8E44

Q37050510-370CCD0A-7AC9-4B2D-9580-6ADBB11003AD

Q37050510-52AEB6C0-5D9A-4D62-8E40-9A59A6DCBA7E

Q37050510-58AF4028-0B99-45D6-A816-4543A5410744

Q37050510-96D8F6F1-9DAD-4D00-8B08-4C8D0FC897D3

Q37050510-C3331FEC-A5FD-41B3-AE39-02AF8930B7EA

P2860

Q37050510-0B51F102-06FB-48B2-86E0-9422AE6E7FCD

Q37050510-19B8E189-C5B0-4B0A-99BE-AF91E27FE227

Q37050510-24052DBD-9A12-42CA-AA4F-808E54424440

Q37050510-3076F7B9-D994-4896-8BF6-52444434FFA6

Q37050510-398030E7-0070-4346-BEEA-E51E394DB63F

Q37050510-44207118-E084-4101-9451-3F975DBE2080

Q37050510-5ADA726B-E081-4091-9778-9C50EEB91AFC

Q37050510-61A62117-6DA9-4A64-ABDB-A89DEF9A4FBC

Q37050510-6A500B61-DF49-4A00-92C7-8E9398BE5483

Q37050510-6F6D45C5-5345-42C0-AA98-F74467B03213

P304

Q37050510-4C789BAA-C7EE-4013-AFF6-EC66C44506B0

P31

Q37050510-AA47F762-3270-423F-A172-F730232EE779

P356

Q37050510-83AD427A-9987-4853-A698-3BA30AB221CE

P407

Q37050510-DAB3515A-4B95-47CE-8FB8-E5C3DCA549E4

P433

Q37050510-CFBBB85F-BDC7-4802-AA3F-B161D16BA113

P478

Q37050510-05BEC08F-5C3F-4D48-8BA6-F5D914BD4D65

P577

Q37050510-54F11551-07B4-4C7E-B764-68953D28EE88

P5875

Q37050510-14081B9A-F98A-40BC-9590-B54D24D942C3

P698

Q37050510-0C72DE1F-A1B8-4E2A-83D7-C0F0DAE640E0

P932

Q37050510-3A0B8BC6-39C4-45F9-BF2C-D5D32B31DA29

P356

WJG.V19.I28.4568

P1433

World Journal of Gastroenterology

P1476

Fibroblast growth factor recep ...... inese gastric cancer patients.

@en

P2093

Dan-Ping Shen

http://www.w3.org/2001/XMLSchema#string

Guan-Shan Zhu

http://www.w3.org/2001/XMLSchema#string

Xiao-Lu Yin

http://www.w3.org/2001/XMLSchema#string

Xin-Ying Su

http://www.w3.org/2001/XMLSchema#string

Xing-Zhi Ni

http://www.w3.org/2001/XMLSchema#string

Ya-Chao Lu

http://www.w3.org/2001/XMLSchema#string

Yan-Ying Shen

http://www.w3.org/2001/XMLSchema#string

Yuan-Jie Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

FGFR4 Gly388Arg polymorphism contributes to prostate cancer development and progression: a meta-analysis of 2618 cases and 2305 controls

Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab.

Fibroblast growth factor receptor 4 polymorphisms and susceptibility to coronary artery disease.

Further observations on the relationship between the FGFR4 Gly388Arg polymorphism and lung cancer prognosis

Joint association of polymorphism of the FGFR4 gene and mutation TP53 gene with bladder cancer prognosis.

FGFR4 Arg388 allele correlates with tumour thickness and FGFR4 protein expression with survival of melanoma patients.

G388R mutation of the FGFR4 gene is not relevant to breast cancer prognosis.

Altered fibroblast growth factor receptor 4 stability promotes prostate cancer progression.

Assessment of a HER2 scoring system for gastric cancer: results from a validation study.

P304

4568-4575

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V19.I28.4568

http://www.w3.org/2001/XMLSchema#string

P407

P433

28

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

253649249

http://www.w3.org/2001/XMLSchema#string

P698

23901234

http://www.w3.org/2001/XMLSchema#string

P932

3725383

http://www.w3.org/2001/XMLSchema#string